HomeNDC LookupRxCUI directory › RxCUI 212567

Hydrocortisone 10 MG/ML Topical Spray [Cortizone] — RxCUI 212567

RxNorm drug concept · Semantic branded drug
RxCUI 212567 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI212567
Official nameHydrocortisone 10 MG/ML Topical Spray [Cortizone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCortizone 1 % Topical Spray; Cortizone-10 Quick Shot 1 % Topical Spray; Cortizone 10 MG/ML Topical Spray; Cortizone Quick Shot 10 MG/ML Topical Spray
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
  • What exactly is this enema treating — is it the same as regular colitis medicine?
  • Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
  • How long do I need to use it before it starts working?
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 10 MG/ML Topical Spray [Cortizone... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone 10 MG/ML Topical Spray [Cortizone] RxCUI 212567

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cortizone 1987140
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone Topical Spray 377305
    • Hydrocortisone Topical Product 1164013
    • Hydrocortisone Topical Spray [Cortizone] 1987161
    • Cortizone Topical Product 1987143
    • Topical Spray 346165
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Hydrocortisone 10 MG/ML [Cortizone] SBDC · 1987155
  • Hydrocortisone Topical Spray [Cortizone] SBDF · 1987161
  • Cortizone Topical Product SBDG · 1987143
  • Cortizone BN · 1987140

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 212567 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
41167-0343-00 76 g in 1 BOTTLE (41167-0343-0) Cortizone 10 Fast Acting Itch Relief Cooling Chattem, Inc. 2025-01-03
Observed labelers: Chattem, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.